Moneycontrol PRO
you are here: HomeNewsRanbaxy
ranbaxy
Jump to
510 Results Found
  • Veterans Unpacked | D.S. Brar: "Your network is your net worth, and your credibility is your currency" Jul 31, 2021 01:27 PM IST

    Veterans Unpacked | D.S. Brar: "Your network is your net worth, and your credibility is your currency"

    His advice to young leaders: "Focus on relationships and building trust with your customers, your partners and your employees."

  • SC holds Singh brothers guilty of contempt in Daiichi Sankyo case Nov 15, 2019 11:55 AM IST

    SC holds Singh brothers guilty of contempt in Daiichi Sankyo case

    The apex court earlier asked former Ranbaxy promoters Malvinder Singh and Shivinder Singh to give it a plan as to how they would honour the arbitral award of Rs 3,500 crore granted by a Singapore tribunal against them and in favour of Japanese drug manufacturer Daiichi Sankyo.

  • Delhi Police arrests former Ranbaxy promoter Shivinder Singh Oct 10, 2019 06:11 PM IST

    Delhi Police arrests former Ranbaxy promoter Shivinder Singh

    The EOW of Delhi Police is also on the lookout for former Ranbaxy CEO Malvinder Singh.

  • Policy| Bottle of Lies: What ails India’s drug industry Jun 10, 2019 12:25 PM IST

    Policy| Bottle of Lies: What ails India’s drug industry

    Like other books on corporate fraud, Bottle of Lies is a cautionary tale about how the relentless quest for high growth and profits at any costs can corrupt organisations in the absence of a strong, ethical core and sustained, rigorous, regulatory oversight.

  • SC asks ex-Ranbaxy promoters to apprise how they'll comply with Rs 3500 crore arbitral award Mar 14, 2019 12:58 PM IST

    SC asks ex-Ranbaxy promoters to apprise how they'll comply with Rs 3500 crore arbitral award

    A bench headed by Chief Justice Ranjan Googi asked the Singh brothers, who were present in the court, to consult their financial and legal advisors and give a concrete plan on how they will comply with the tribunal's order.

  • Opinion | Sun Pharma: New governance structure needed to protect investors' interest Jan 01, 2019 01:57 PM IST

    Opinion | Sun Pharma: New governance structure needed to protect investors' interest

    The whistleblower allegations have raised governance concerns at Sun Pharma. Investors are better placed in proactively raising their concerns with the board, to ensure that the new governance structure at Sun Pharma is robust, in their compliance and intent

  • NCLT dismisses HDFC plea for initiating insolvency proceedings against RHC Holding Dec 06, 2018 04:34 PM IST

    NCLT dismisses HDFC plea for initiating insolvency proceedings against RHC Holding

    The Delhi High Court has already granted a status quo over sale of assets by RHC Holding.

  • A message for Indian pharma: Do what you say, say what you do Mar 21, 2017 09:34 PM IST

    A message for Indian pharma: Do what you say, say what you do

    Over the last decade, “data integrity” has turned out to be the most discussed and perhaps the most dreaded word for the Indian pharmaceutical companies.

  • Analysts retain buy on Sun Pharma as USFDA clears Mohali, Halol unit resolution key Mar 15, 2017 12:54 PM IST

    Analysts retain buy on Sun Pharma as USFDA clears Mohali, Halol unit resolution key

    CLSA says Mohali plant clearance is a significant positive development for the company and shows progress on regulatory issues. Clearance makes a large oral solid dosage site available to de-risk existing sites.

  • USFDA lifts import ban on Sun Pharma's Mohali plant, shares surge 5% Mar 14, 2017 02:44 PM IST

    USFDA lifts import ban on Sun Pharma's Mohali plant, shares surge 5%

    Sun Pharma said the proposed action will clear path for supply approved products from the Mohali faciity to the US market.

  • Sun Pharma soars 6% on US FDA’s plan to lift import alert at Mohali Mar 14, 2017 02:07 PM IST

    Sun Pharma soars 6% on US FDA’s plan to lift import alert at Mohali

    The company informed the exchanges that the US Food and Drug Administration was planning to remove the firm from Official Action Initiated (OIA) status.

  • Trump policies stressful for India pharma cos: Ex-Ranbaxy CEO Feb 22, 2017 10:42 AM IST

    Trump policies stressful for India pharma cos: Ex-Ranbaxy CEO

    Former CEO of Ranbaxy, Brian Tempest, expects more pricing pressure to come in US under Donald Trump administration.

  • Daiichi to shut down Indian R&D centre; 170 employees impacted Jan 11, 2017 12:57 PM IST

    Daiichi to shut down Indian R&D centre; 170 employees impacted

    “Daiichi Sankyo is reviewing its global R&D system with the aim of decreasing R&D operations costs and redistributing resources to the further development of its R&D pipeline,” the company said in a statement.

  • Nifty on Cloud Nine! 9 stocks with a high margin of safety Jan 01, 2017 12:00 AM IST

    Nifty on Cloud Nine! 9 stocks with a high margin of safety

    With Nifty a whisker away from its lifetime high and valuation touching 21X FY17P and 18X FY18P earnings, the Street looks cautious. Is it time to take money off the table?

  • COMMENT: Is Sun Pharma suffering on account of unrelated diversification? Dec 21, 2016 06:24 PM IST

    COMMENT: Is Sun Pharma suffering on account of unrelated diversification?

    For investors, the Sun Pharma stock has long stood for a focus on growth, both through organic and inorganic routes. Is this lack of focus through unrelated investments the reason for its underperformance?

  • Sun Pharma, Wockhardt in news on re-inspections, lawsuits Nov 21, 2016 08:55 AM IST

    Sun Pharma, Wockhardt in news on re-inspections, lawsuits

    Wockhardt, Sun Pharma, Tara, Novartis and other pharma company Perrigo are also in focus on account of reports from the US that there are lawsuits filed by Unions representing the New York Police Department on price collusion of two dermatology products.

  • Positive on ITC & ICICI Bank, says Deven Choksey Nov 04, 2016 10:44 AM IST

    Positive on ITC & ICICI Bank, says Deven Choksey

    In an interview to CNBC-TV18, Deven Choksey, MD of KRChoksey Investment Managers Private Limited shared his readings and outlook on specific stocks and sectors.

  • Look at Sun Pharma, says Gaurang Shah Aug 26, 2016 04:12 PM IST

    Look at Sun Pharma, says Gaurang Shah

    Gaurang Shah of Geojit BNP Paribas is of the view that one may look at Sun Pharmaceutical Industries.

  • Continue to remain opportunistic for acquisitions: Sun Pharma Jun 07, 2016 08:46 AM IST

    Continue to remain opportunistic for acquisitions: Sun Pharma

    The merger between Sun and Ranbaxy achieved closure towards the end of March 2015.

  • Sun Pharma falls 6% on weak sales guidance, price pressure woes May 31, 2016 01:25 PM IST

    Sun Pharma falls 6% on weak sales guidance, price pressure woes

    The company also said that the pharma major will continue to build speciality business which could impact short term profitability. It also cautioned that it could lose anywhere between 5-10 percent due to pricing pressure and peer consolidation in the US.

  • Sun Pharma, Daiichi terminate transaction pacts May 26, 2016 09:54 PM IST

    Sun Pharma, Daiichi terminate transaction pacts

    Daiichi Sankyo, Daiichi Sankyo (Thailand) Ltd, Sun Pharmaceutical Industries Ltd, Ranbaxy (Netherlands) BV and Ranbaxy (Thailand) Company Ltd entered into a termination agreement on May 26, 2016.

  • More trouble for Ranbaxy as central regulator finds deficiencies May 09, 2016 03:18 PM IST

    More trouble for Ranbaxy as central regulator finds deficiencies

    Joint inspections with eight other regulators carried at six of Ranbaxy‘s laboratories in Himachal Pradesh found discrepancies in testing, stability standards and expiry dates, among other standards.

  • CCI okays PVR-DT Cinemas deal, asks to exclude certain assets May 06, 2016 01:50 PM IST

    CCI okays PVR-DT Cinemas deal, asks to exclude certain assets

    In a tweet, the watchdog today said it has cleared "PVR's acquisition of DT Cinema's multiplexes/single screen theaters in Delhi NCR and Chandigarh, subject to modification".

  • Ex-Ranbaxy promoters fined $400mn for hiding info from Daiichi May 05, 2016 08:47 PM IST

    Ex-Ranbaxy promoters fined $400mn for hiding info from Daiichi

    Malvinder and Shivinder Singh had sold their stake in Ranbaxy Laboratories to Daiichi way back in 2008, following which Daiichi-led Ranbaxy was forced to pay the US Department of Justice a sum of USD 500 million over non-compliance with US Food and Drug Administration's testing norms.

  • Pharma whistleblower: Consumers must question medicines' quality Apr 30, 2016 12:02 PM IST

    Pharma whistleblower: Consumers must question medicines' quality

    The past few years have been rough of Indian pharma companies, what with the US FDA raking them over the coals over alleged manufacturing lapses and discrepancies.

Sections
ISO 27001 - BSI Assurance Mark